Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
,
Founded in 2020
51-200 employees
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2020
- Employee Range
- 51-200
- Revenue Range
- Not available
Location
- Address
- City
- Region
- Postal Code
- 92037
- Country
- United States
Web Presence
Websiteshorelinebio.com
LinkedIn0 followers